Alyeska Investment Group’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-33,285
| Closed | -$1.14M | – | 507 |
|
|
2020
Q2 | $1.14M | Buy |
+33,285
| New | +$1.14M | 0.02% | 382 |
|
|
2018
Q1 | – | Sell |
-300,000
| Closed | -$1.83M | – | 425 |
|
|
2017
Q4 | $1.83M | Buy |
+300,000
| New | +$1.83M | 0.01% | 320 |
|
|
2016
Q1 | – | Sell |
-168,881
| Closed | -$569K | – | 395 |
|
|
2015
Q4 | $569K | Sell |
168,881
-10,505
| -6% | -$35.4K | 0.01% | 345 |
|
|
2015
Q3 | $956K | Sell |
179,386
-33,781
| -16% | -$180K | 0.01% | 386 |
|
|
2015
Q2 | $1.38M | Buy |
213,167
+130,604
| +158% | +$845K | 0.02% | 361 |
|
|
2015
Q1 | $404K | Buy |
82,563
+6,069
| +8% | +$29.7K | 0.01% | 448 |
|
|
2014
Q4 | $385K | Buy |
76,494
+25,012
| +49% | +$126K | 0.01% | 433 |
|
|
2014
Q3 | $263K | Buy |
51,482
+405
| +0.8% | +$2.07K | 0.01% | 346 |
|
|
2014
Q2 | $322K | Buy |
+51,077
| New | +$322K | 0.01% | 346 |
|